BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 3.625
+0.125 (3.57%)
Sep 25, 2026, 3:18 PM CET
BIOTON Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 257.23 | 282.52 | 207.76 | 181.64 | 233.16 | 163.03 | |
Revenue Growth | -2.98% | 35.98% | 14.38% | -22.10% | 43.01% | -26.49% |
Cost of Revenue | 161.78 | 190.72 | 142.92 | 108.78 | 137.41 | 86.72 |
Gross Profit | 95.45 | 91.8 | 64.84 | 72.85 | 95.75 | 76.32 |
Selling, General & Admin | 76.76 | 73.4 | 67.2 | 71.46 | 65.34 | 59.69 |
Research & Development | 4.11 | 3.98 | 4.04 | 5.51 | 5.34 | 4.67 |
Other Operating Expenses | 18.07 | 1.11 | -0.81 | -0.39 | 0.92 | -1.49 |
Operating Expenses | 98.93 | 78.48 | 70.43 | 76.58 | 71.6 | 62.87 |
Operating Income | -3.49 | 13.32 | -5.59 | -3.72 | 24.15 | 13.45 |
Interest Expense | -4.86 | -5.07 | -7.53 | -8.24 | -7.86 | -4.54 |
Interest & Investment Income | 0 | 0.15 | 0.2 | - | - | - |
Currency Exchange Gain (Loss) | 0.7 | -0.17 | 1.58 | 0.37 | -7.86 | -1.37 |
Other Non Operating Income (Expenses) | -0.44 | -0.41 | -0.42 | -0.18 | -0.59 | -0.1 |
EBT Excluding Unusual Items | -8.08 | 7.82 | -11.77 | -11.78 | 7.85 | 7.44 |
Merger & Restructuring Charges | -0.13 | - | -0.09 | -0.04 | 0.01 | -0.17 |
Gain (Loss) on Sale of Assets | 0.04 | 0.01 | -0.03 | 3.11 | -0.6 | 2.66 |
Asset Writedown | 0.31 | - | -0.08 | -0.01 | -2.72 | -1.6 |
Legal Settlements | 0.01 | - | 0.01 | - | 0.3 | - |
Other Unusual Items | - | - | 0.07 | 15.95 | 0.12 | - |
Pretax Income | -7.84 | 7.83 | -11.88 | 7.23 | 4.95 | 8.33 |
Income Tax Expense | 0.52 | 4.44 | 3.78 | 4.96 | 3.53 | 5.45 |
Earnings From Continuing Operations | -8.35 | 3.39 | -15.66 | 2.28 | 1.42 | 2.88 |
Net Income to Company | -8.35 | 3.39 | -15.66 | 2.28 | 1.42 | 2.88 |
Net Income | -8.35 | 3.39 | -15.66 | 2.28 | 1.42 | 2.88 |
Net Income to Common | -8.35 | 3.39 | -15.66 | 2.28 | 1.42 | 2.88 |
Net Income Growth | - | - | - | 60.10% | -50.69% | -91.50% |
Shares Outstanding (Basic) | 86 | 86 | 86 | 86 | 86 | 86 |
Shares Outstanding (Diluted) | 86 | 86 | 86 | 86 | 86 | 86 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.10 | 0.04 | -0.18 | 0.03 | 0.02 | 0.03 |
EPS (Diluted) | -0.10 | 0.04 | -0.18 | 0.03 | 0.02 | 0.03 |
EPS Growth | - | - | - | 60.10% | -44.84% | -92.41% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.48 | 9.55 | 25.14 | -4.54 | 26.5 | -7.37 |
Free Cash Flow Per Share | -0.11 | 0.11 | 0.29 | -0.05 | 0.31 | -0.09 |
Gross Margin | 37.10% | 32.49% | 31.21% | 40.11% | 41.07% | 46.81% |
Operating Margin | -1.36% | 4.71% | -2.69% | -2.05% | 10.36% | 8.25% |
Profit Margin | -3.25% | 1.20% | -7.54% | 1.25% | 0.61% | 1.77% |
Free Cash Flow Margin | -3.69% | 3.38% | 12.10% | -2.50% | 11.37% | -4.52% |
EBITDA | 28.3 | 51.78 | 18.83 | 31.26 | 58.56 | 45.09 |
EBITDA Margin | 11.00% | 18.33% | 9.06% | 17.21% | 25.11% | 27.66% |
D&A For EBITDA | 31.79 | 38.47 | 24.42 | 34.98 | 34.4 | 31.64 |
EBIT | -3.49 | 13.32 | -5.59 | -3.72 | 24.15 | 13.45 |
EBIT Margin | -1.36% | 4.71% | -2.69% | -2.05% | 10.36% | 8.25% |
Effective Tax Rate | - | 56.67% | - | 68.55% | 71.30% | 65.41% |
Advertising Expenses | - | - | 7.26 | 10.14 | 8.28 | 7.26 |